CSEM is a Swiss research and technology organization which delivers advanced technologies and unique R&D services to industry in a wide range of fields. In the field of biotechnology CSEM provides and develops customized solutions for sensors, tools, instrumentation and automation by uniting expertise from the areas of surface treatment, cell culture supports & microcarriers, cell & liquid handling, microfluidics, (bio)sensors, integration, and automation.
Experts in biochemical and molecular bioanalytics, diagnostics, medicional chemistry, pharmacology and toxicology.
HES-SO, Faculty of Engineering and Architecture
HES-SO is the largest University of Applied Sciences in Switzerland and is strongly anchored into the regional, economic, and social activities. With over 20’000 students, it is organised in 6 faculties, 27 schools offering 61 Bachelor and Master study programmes.
The Faculty of Engineering and Architecture is divided in 4 fields, namely Chemistry and Life sciences, Construction and Environment, Industrial technologies and information as well as Communication technologies spread out in 6 schools. Its applied research meets not only the needs of society but also those of industry. With 32 research institutes, the Faculty of Engineering and Architecture has a turnover around 50 million swiss francs in 2014.
The International Entrepreneurial School® MCI - Management Center Innsbruck offers graduate, non-graduate and post-graduate educational programs in the fields of Technology & Life Sciences and Management & Society.
At MCI in the research field of “Algal Biotechnology”, yet unresearched biobanks, e.g. a collection of terrestrial algae, are undergoing screening in search of innovative active agents and products for the pharmaceutical, cosmetics and food industries, taking account of the complete process chain, from cultivation to isolation and analysis. Furthermore, microalgae regarded as safe such as Chlamydomonas reinhardtii are investigated for the production of recombinant proteins, e.g. allergens for specific immunotherapy. The research field “Renewable Energy” is focused on Valorisation of Biomass, Biomass gasification, Engine Technology and Energy Distribution and Storage. Main activities in the research area “Process Technology” are preparation of novel membranes, design of new Advanced Oxidation Processes and the implementation of these techniques into the field of Water and wastewater treatment as well as the whole field of downstream processing.
Wyss Zurich is a joint research and development center of ETH Zurich and the University of Zurich dedicated to the emerging fields of regenerative medicine and robotics. The center unites world-leading experts from both institutions in multidisciplinary teams, pooling their knowledge and expertise. The mission of Wyss Zurich is to drive the translation of outstanding scientific discoveries into new cures for patients and breakthrough innovations. In a unique all-in-one approach, Wyss Zurich provides its members with: funding to cover personnel expenses and translational R&D, notably early phase clinical trials; access to world-class infrastructures, including a dedicated facility to produce compounds that can be used in humans; and support in the design, analysis and business strategy of the projects by subject-matter experts.Wyss Zurich was made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. hc. mult. Hansjörg Wyss.
Biotechnology: research is oriented towards processes using microorganisms and plant/animal cell cultures for the manufacturing (i.e. synthesis and transformation), decomposition and analysis of substances including molecular and cell biology. The resulting products and processes are applied in pharmaceutical, food and natural resources fields.
Chemistry and biological chemistry: specialized in chemical and biochemical engineering, (bio)chemical measure and sensor technologies as well as specialty chemistry.
The Platform for stem cells and regenerative medicine (SCRM; www.stemcellsbern.ch) is a supra-faculty research cluster affiliated with the Department of BioMedical Research (DBMR) at the University of Bern. SCRM comprises 37 member groups in stem cell research from the Medical Faculty and Insel, Bern University Hospital as well as the Vetsuisse and Phil.-nat. Faculties. The SCRM Mission is to support innovative and high quality research at the University of Bern and Insel, Bern University Hospital and efficiently and rapidly transfer basic findings on cell therapy into clinical applications.
The SCRM Platform supports and connects Bernese scientists with activities in stem cell research and regenerative medicine with the goal to foster innovation through support of
young researchers (PhD Retreat, Stem Cell Lunch Seminar; PhD Curriculum in stem cells and regenerative medicine)
exchanges between established Bernese research groups in stem cell research and RegMed (Stem Cell Lunch Seminar; Home page; News Letter)
national and international networking (e.g. Meeting Cell Therapy 2016)